[Skip to Content]
[Skip to Content Landing]
August 1957

Plasma Thromboplastin Antecedent (PTA) Deficiency

Author Affiliations


From the Blood Research Laboratory, a unit of the Ziskind Laboratories, New England Center Hospital, and the Department of Medicine, Tufts University Medical School.

AMA Arch Intern Med. 1957;100(2):232-240. doi:10.1001/archinte.1957.00260080058012

Plasma thromboplastin antecedent (PTA) deficiency was first described by R. L. Rosenthal et al., in 1953,1 as a mild to moderately severe hereditary hemorrhagic disease resembling hemophilia but occurring in both males and females. Further studies by the same group revealed fairly well-defined distinctions between antihemophilic globulin (AHG), plasma thromboplastin component (PTC), and PTA.2 Only a few subsequent cases of PTA deficiency have been reported.3,4 The present report deals with a family in which a coagulation disorder, eventually diagnosed as PTA deficiency, was found.* Both males and females were affected, inheritance taking place either through males or females. Of the 10 members of the family available for study, 5 showed indications of the disease (Fig. 1). However, the variability in laboratory tests indicated a somewhat less well-defined character of the deficient factor than is found in either the AHG or the PTC coagulation defect. In the case

First Page Preview View Large
First page PDF preview
First page PDF preview